| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Okey Stephanie is a Director at CRNX, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 8 sales. Those positions are worth an estimated $269K at current prices.
Our model assigns Okey Stephanie a middling insider score of 55/100, based on 6 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -1.3%.
Okey Stephanie's largest disclosed position is in PTCT as Director, worth about $269K. The recent filings there lean toward selling, a net 31,133 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE10b5-1 | 15,167 | $70.00 | $1,061,690.00 | -65.5% | +3.4% | - | |
| Mar 5, 2026 | PTCT Ptc Therapeutics, Inc. | Director | Sell10b5-1 | 6,333 | $63.38 | $401,385.54 | -44.2% | +8.4% | - | |
| Mar 13, 2025 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 5,000 | $54.00 | $270,000.00 | -36.1% | -3.7% | +22.2% | |
| Mar 28, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Director | Sale+OE | 17,500 | $46.38 | $811,650.00 | -74.5% | -9.9% | -25.8% | |
| Aug 9, 2022 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 2,296 | $51.62 | $118,521.82 | -55.2% | -32.9% | -23.0% | |
| Aug 13, 2021 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 1,650 | $40.06 | $66,094.05 | -63.1% | -0.7% | +31.8% | |
| Dec 8, 2020 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 687 | $62.52 | $42,953.99 | -41.6% | - | - |